# Ocular Oncology and Treatments

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/ocular-oncology-and-treatments/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the research, diagnosis, and treatment of ocular cancers, particularly uveal melanoma and retinoblastoma. It covers topics such as genetic mutations, metastatic disease, various treatment modalities including radiation therapy and intraocular chemotherapy, prognostic factors, and tumor classification. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11328 |
| Works | 84 |

## Topic papers all

Showing 15 of 84.

- [Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma](https://scholariq.org/papers/completion-dissection-or-observation-for-sentinel-node-metastasis-in-melanoma/)
- [Cellular mechanisms of tumour suppression by the retinoblastoma gene](https://scholariq.org/papers/cellular-mechanisms-of-tumour-suppression-by-the-retinoblastoma-gene/)
- [Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [Incidence of noncutaneous melanomas in the U.S.](https://scholariq.org/papers/incidence-of-noncutaneous-melanomas-in-the-u-s/)
- [Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma](https://scholariq.org/papers/development-of-metastatic-disease-after-enrollment-in-the-coms-trials-for/)
- [Inactivation of the p53 pathway in retinoblastoma](https://scholariq.org/papers/inactivation-of-the-p53-pathway-in-retinoblastoma/)
- [Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial](https://scholariq.org/papers/activity-of-the-oral-mek-inhibitor-trametinib-in-patients-with-advanced-melanoma/)
- [Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry](https://scholariq.org/papers/acute-mutation-of-retinoblastoma-gene-function-is-sufficient-for-cell-cycle-re/)
- [Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy](https://scholariq.org/papers/outcome-for-children-with-medulloblastoma-treated-with-radiation-and-cisplatin/)
- [Incidence of Uveal Melanoma in Europe](https://scholariq.org/papers/incidence-of-uveal-melanoma-in-europe/)
- [Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme](https://scholariq.org/papers/phase-ii-study-of-bevacizumab-plus-temozolomide-during-and-after-radiation/)
- [Clinical Patterns and Characteristics of Uveitis in a Tertiary Center for Uveitis in China](https://scholariq.org/papers/clinical-patterns-and-characteristics-of-uveitis-in-a-tertiary-center-for/)
- [Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia](https://scholariq.org/papers/verteporfin-therapy-of-subfoveal-choroidal-neovascularization-in-pathologic/)
- [Conjunctival and Corneal Intraepithelial and Invasive Neoplasia](https://scholariq.org/papers/conjunctival-and-corneal-intraepithelial-and-invasive-neoplasia/)
- [Aqueous Shunts in Glaucoma](https://scholariq.org/papers/aqueous-shunts-in-glaucoma/)

## Topic primary papers

Showing 15 of 28.

- [Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [Incidence of noncutaneous melanomas in the U.S.](https://scholariq.org/papers/incidence-of-noncutaneous-melanomas-in-the-u-s/)
- [Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma](https://scholariq.org/papers/development-of-metastatic-disease-after-enrollment-in-the-coms-trials-for/)
- [Incidence of Uveal Melanoma in Europe](https://scholariq.org/papers/incidence-of-uveal-melanoma-in-europe/)
- [Conjunctival and Corneal Intraepithelial and Invasive Neoplasia](https://scholariq.org/papers/conjunctival-and-corneal-intraepithelial-and-invasive-neoplasia/)
- [Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study](https://scholariq.org/papers/treatment-of-metastatic-uveal-melanoma-with-adoptive-transfer-of-tumour/)
- [Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/three-year-overall-survival-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families](https://scholariq.org/papers/germline-bap1-inactivation-is-preferentially-associated-with-metastatic-ocular/)
- [Screening for Metastasis From Choroidal Melanoma: The Collaborative Ocular Melanoma Study Group Report 23](https://scholariq.org/papers/screening-for-metastasis-from-choroidal-melanoma-the-collaborative-ocular/)
- [Clinical presentation and survival of retinoblastoma in Indian children](https://scholariq.org/papers/clinical-presentation-and-survival-of-retinoblastoma-in-indian-children/)
- [Extraocular retinoblastoma: A 13‐year experience](https://scholariq.org/papers/extraocular-retinoblastoma-a-13-year-experience/)
- [Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma](https://scholariq.org/papers/ethnic-racial-and-socioeconomic-disparities-in-retinoblastoma/)
- [Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study](https://scholariq.org/papers/prognostic-significance-of-chromosome-3-alterations-determined-by-microsatellite/)
- [INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF SUBRETINAL FLUID ASSOCIATED WITH CHOROIDAL OSTEOMA](https://scholariq.org/papers/intravitreal-bevacizumab-in-the-management-of-subretinal-fluid-associated-with/)
- [Retinoblastoma in Turkey: survival and clinical characteristics 1981–2004](https://scholariq.org/papers/retinoblastoma-in-turkey-survival-and-clinical-characteristics-1981-2004/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.